MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Characteristics of Visual Hallucinations in Lewy Body Dementia

    Y. Luo, RY. Lo, J. Wang (Hsinchu, Taiwan)

    Objective: To investigate the risk and the content of visual hallucination (VH) among patients with Lewy body dementia (LBD) within the cultural background of Taiwan.…
  • 2025 International Congress

    Longitudinal Brain Morphometric Trajectories Across Parkinson Disease Clinical Subtypes

    A. Eid, S. Grossen, A. Tanenbaum, J. Hood, H. Hwang, T. Cash, C. Lessov-Schlaggar, J. Jackson, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

    Objective: To investigate longitudinal brain morphometric trajectories across Parkinson disease (PD) clinical subtypes Background: We developed a PD multi-domain classification based on motor and non-motor…
  • 2025 International Congress

    Theta-Burst Subthalamic Deep Brain Stimulation for Parkinson’s Disease: A Pilot Study of Motor and Cognitive Effects

    X. Mason, K. Wu, M. Abu-Zahra, W. Choi, J. Cavaleri, R. Briggs, C. Mark, B. Lee, M. Wilson, D. Lee (Los Angeles, USA)

    Objective: To evaluate the feasibility and preliminary effects of theta-burst stimulation (TBS) on motor function and verbal fluency in Parkinson’s disease (PD) patients with subthalamic…
  • 2025 International Congress

    Huntington disease in a Patient with Extensive Psychiatric History

    A. Sim, A. Drozdov, D. Carrillo, L. Acosta (El Paso, USA)

    Objective: Huntington's Disease (HD) is an autosomal dominant neurodegenerative disorder resulting from an expansion of CAG trinucleotide repeats in the gene encoding the huntingtin protein.…
  • 2025 International Congress

    Zonisamide for Motor Symptoms and OFF-Time Reduction in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)

    Objective: To evaluate the efficacy and safety of zonisamide as an adjunct therapy for improving motor function and reducing OFF-time in patients with Parkinson’s disease…
  • 2025 International Congress

    Comparative Analysis of MoCA Scores Between Latin American Latinos and White Patients with Parkinson’s Disease

    S. Sperling, S. Anis, H. Mauricio Chaparro-Solano, T. Peixoto Leal, C. Sonneborn, C. Callegari Piccini, M. Inca-Martinez, M. Cornejo-Olivas, M. Illanes-Manrique, P. Chana-Cuevas, P. Safie Awad, A. Jimena Hernández-Medrano, A. Cervantes-Arriaga, A. Schuh, C. Rieder, P. Braga-Neto, A. Silva Sena, B. Lopes Santos-Lobato, E. Gatto, G. Alvarado, C. Avila, V. Tumas, M. Paula Foss, V. Borges, H. Ballalai Ferraz, J. Orozco Vélez, B. Muñoz Ospina, S. Moreno, D. Pineda, J. Rios Pinto, P. Olguín, J. Cristobal Nuñez, A. Viñuela, A. Espinal-Martinez, N. Mori, K. Mejía-Rojas, A. Medina-Colque, A. Zuma Rosso, C. Vilaça, E. Ochoa-Valle, I. Cornejo-Herrera, P. Reyes-Perez, A. Lázaro-Figueroa, A. Moraes Alves, R. Gisbert Cury, H. Fernandez, I. Mata (Cleveland, USA)

    Objective: The study objectives were to 1) characterize scores on the Montreal Cognitive Assessment (MoCA) in patients with Parkinson’s disease (PD) from Latin America, 2)…
  • 2025 International Congress

    Time perception patterns in patients with Parkinson’s disease and Alzheimer’s disease

    A. Chimagomedova, O. Levin (Moscow, Russian Federation)

    Objective: We conducted this study to assess different patterns of time perception in patients with Parkinson’s disease (PD) and Alzheimer’s disease (AD). Background: Time perception…
  • 2025 International Congress

    Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

    A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)

    Objective: The presented case report aims to show the possible overlap between causes of neurocognitive decline and the importance of considering comorbidities when discussing anti-amyloid monoclonal…
  • 2025 International Congress

    Hippocampal-striatal interaction and cognitive decline in Parkinson’s disease with mild cognitive impairment

    S. Tan, X. Zhang, J. Wen, X. Xu, Z. Zhang, J. Xu (Hangzhou, China)

    Objective: We aimed to investigate the interaction between hippocampus and dopaminergic pathways in PD with mild cognitive impairment (PD-MCI). Background: Dysfunction of striatal dopaminergic neurotransmitter…
  • 2025 International Congress

    Performance Validity Test Failure Base Rates Among Presurgical Movement Disorder Patients

    J. Numerick, A. Karstens, D. Gonzalez, D. Ulrich (Chicago, USA)

    Objective: This study investigated the base rates of performance validity test (PVT) failure on neuropsychological testing in a sample of patients seeking surgical intervention (DBS/MRgFUS)…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley